Sr-89 - Chloride for Injection

 
Isotope Sr-89 Chloride for Injection

Specifications

AVAILABILITY
HALF-LIFE
50,55 days
APPLICATION: Strontium-89 Chloride Injection is mainly used for treatment of pain caused by metastasis of advanced malignant cancer such as prostate cancer, breast cancer, lung cancer and nasopharyngeal carcinoma, and inhibits the new metastasis of malignant cancers. 
CHARACTERISTICS: The maximum of β-ray that emitted by it is 14.6MeV. 8 mm is the maximum emission range in soft tissue, and 3 mm in bone tissue.
PROCESS DATA
	Strontium-89 (Sr-89) chloride in the treatment of various cancer patients with multiple bone metastases
Strontium-89 (Sr-89) chloride in the treatment of various cancer patients with multiple bone metastases
Comparison of the efficacy of strontium-89 chloride in treating bone metastasis of lung, breast, and prostate cancers
Comparison of the efficacy of strontium-89 chloride in treating bone metastasis of lung, breast, and prostate cancers
FUTURE POSSIBILITIES FOR MEDICAL RADIOISOTOPE PRODUCTION IN RESEARCH REACTORS
FUTURE POSSIBILITIES FOR MEDICAL RADIOISOTOPE PRODUCTION IN RESEARCH REACTORS